BioCentury | Feb 5, 2015
Distillery Therapeutics

Therapeutics: Kruppel-like factor 10 (KLF10)

...a new KLF10 inhibitor could help improve the efficacy of cancer immunotherapy. The transcription factor KLF10...
...tumors. Screening of small molecules in a cell-based assay identified a lead compound that inhibited KLF10...
...models of cancer and the development of mice with T cell-specific knockout of KLF10. TARGET/MARKER/PATHWAY: Kruppel-like factor 10 (KLF10)...
Items per page:
1 - 1 of 1